Previous in vivo studies demonstrated that free systemically administered tesa can reduce hypertriglyceridemia, hyperinsulinemia, and hyperglycemia in ob/ob mice and restore insulin sensitivity in obese Zucker rats [43]. Here, INS is linked to hypertriglyceridemia.